285 related articles for article (PubMed ID: 23769743)
1. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
2. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
[TBL] [Abstract][Full Text] [Related]
3. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
4. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat.
Morán A; Fernández MM; Velasco C; Martín ML; San Román L
Br J Pharmacol; 1998 Mar; 123(6):1205-13. PubMed ID: 9559906
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
Morán A; Restrepo B; de Urbina AV; García M; Martín ML; Román LS
Eur J Pharmacol; 2010 Sep; 643(1):70-7. PubMed ID: 20547148
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
[TBL] [Abstract][Full Text] [Related]
7. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
[TBL] [Abstract][Full Text] [Related]
8. Blockade of 5-HT
Hernández-Abreu OI; García-Pedraza JÁ; Rivera-Mancilla E; Villanueva-Castillo B; Morán A; García-Domingo M; Manrique-Maldonado G; Altamirano-Espinoza AH; Villalón CM
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):403-411. PubMed ID: 31846086
[TBL] [Abstract][Full Text] [Related]
9. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats.
Morán A; Velasco C; Salvador T; Martín ML; San Román L
Br J Pharmacol; 1994 Dec; 113(4):1358-62. PubMed ID: 7889292
[TBL] [Abstract][Full Text] [Related]
11. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Fernández-González JF; García-Pedraza JÁ; Marín-Quílez A; Bastida JM; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2022 Sep; 153():113276. PubMed ID: 35717784
[TBL] [Abstract][Full Text] [Related]
12. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
García-Pedraza JÁ; López C; Fernández-González JF; Martín ML; Morán A; García-Domingo M
J Pharmacol Sci; 2021 Sep; 147(1):48-57. PubMed ID: 34294372
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
[TBL] [Abstract][Full Text] [Related]
14. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
García-Pedraza JÁ; García M; Martín ML; Eleno N; Morán A
J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327
[TBL] [Abstract][Full Text] [Related]
15. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
[TBL] [Abstract][Full Text] [Related]
16. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine oral treatment discloses 5-HT
López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):640-7. PubMed ID: 25854421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]